Voricare

Voriconazole 50 mg, 200 mg tablet

Voricare is a prominent brand of Voriconazole manufactured by Delta Pharma Limited, a leading pharmaceutical company in Bangladesh. It belongs to the triazole class of antifungal medications and is primarily used to treat serious, invasive fungal infections.

Here is a brief overview of the brand:

Indication and Usage

Voricare is prescribed for the treatment of a variety of fungal infections, including:

• Invasive Aspergillosis: Often considered the first-line treatment for this serious lung infection.

• Candidemia: Fungal infections in the blood.

• Esophageal Candidiasis: Fungal infections of the esophagus.

• Serious Fungal Infections: Caused by Scedosporium apiospermum and Fusarium species in patients intolerant of or refractory to other therapy.

Mechanism of Action

Voriconazole works by inhibiting the fungal enzyme 14-$\alpha$-sterol demethylase. This inhibition prevents the synthesis of ergosterol, a vital component of the fungal cell membrane, leading to the collapse of the fungal cell.

Available Dosage Forms

In the Bangladeshi market, Delta Pharma typically offers Voricare in various strengths and forms to ensure flexible dosing:

• Voricare 50 mg & 200 mg Tablet: For oral administration.

• Voricare Injection: Often available as a lyophilized powder for intravenous infusion, used in critical care or hospital settings.

Key Advantages

• Broad Spectrum: Effective against a wide range of yeast and molds.

• Bioavailability: High oral bioavailability, allowing for an easy transition from intravenous to oral therapy once the patient is stable.

• Established Quality: Delta Pharma is known for maintaining international standards in its manufacturing processes, making Voricare a trusted choice for healthcare professionals.